Respiratory Consequences of N95-type Mask Usage in Pregnant Healthcare Workers - A Controlled Clinical Study
NCT ID: NCT02265926
Last Updated: 2014-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2009-09-30
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sublingual Microcirculation Change During Pregnancy and Postpartum Period
NCT03476096
Observational Maternal COVID-19 Vaccination Study
NCT04826640
Breathing Exercise in Pregnancy-induced Hypertension
NCT05828615
Study of Positive Airway Pressure in Preeclampsia to Reduce Blood Pressure
NCT01029691
Risks of COVID19 in the Pregnant Population
NCT04379284
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
N95
Intervention: N95 mask material
N95 mask
N95 mask material used to cover aperture of Hans Rudolph mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N95 mask
N95 mask material used to cover aperture of Hans Rudolph mask
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Haemoglobinopathies.
21 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University Health System, Singapore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pearl Tong
Associate Consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eu-Leong Yong, PhD
Role: PRINCIPAL_INVESTIGATOR
NUHS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NUHS
Singapore, , Singapore
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010/00226
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.